Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates

Core Insights - Aemetis reported a quarterly loss of $0.66 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.58, marking an earnings surprise of -13.79% [1] - The company's revenues for the quarter were $66.56 million, missing the Zacks Consensus Estimate by 11.69%, compared to $45.11 million in the same quarter last year [1] - Aemetis has consistently failed to meet consensus EPS and revenue estimates over the last four quarters [1] Financial Performance - The company has experienced a significant decline in share price, losing approximately 38.7% since the beginning of the year, while the S&P 500 has gained 15.8% [2] - Current consensus EPS estimate for the upcoming quarter is -$0.33 on revenues of $95.88 million, and for the current fiscal year, it is -$1.57 on revenues of $363.75 million [4] Industry Outlook - The Biofuels industry, to which Aemetis belongs, is currently ranked in the top 40% of over 250 Zacks industries, indicating a relatively strong position [5] - Historical data suggests that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [5]